Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IL-33 antibody

The Mouse Monoclonal anti-IL-33 antibody is suitable to detect IL-33 in samples from Human and Mouse. It has been validated for WB, ELISA and IP.
Catalog No. ABIN1169171
$495.94
Plus shipping costs $50.00
Shipping to: United States
Delivery in 5 to 10 Business Days

Quick Overview for IL-33 antibody (ABIN1169171)

Target

See all IL-33 (IL33) Antibodies
IL-33 (IL33) (Interleukin 33 (IL33))

Reactivity

  • 95
  • 78
  • 52
  • 9
  • 1
Human, Mouse

Host

  • 143
  • 37
  • 4
  • 2
  • 1
  • 1
Mouse

Clonality

  • 136
  • 52
Monoclonal

Conjugate

  • 89
  • 22
  • 16
  • 8
  • 8
  • 8
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This IL-33 antibody is un-conjugated

Application

  • 113
  • 70
  • 61
  • 50
  • 26
  • 24
  • 15
  • 15
  • 11
  • 9
  • 7
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
Western Blotting (WB), ELISA, Immunoprecipitation (IP)

Clone

IL33026B
  • Purpose

    anti-IL-33, mAb (IL33026B)

    Specificity

    Recognizes human and mouse IL-33.

    Characteristics

    Monoclonal Antibody. Recognizes human and mouse IL-33. Isotype: Mouse IgG1kappa. Clone: IL33026B. Applications: ELISA, IP, WB. Liquid. 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives. Interleukin-33 (IL-33, HF-NEV, IL-1F11), a member of the IL-1 family of cytokines, is expressed by many cell types following pro-inflammatory stimulation and is thought to be released on cell lysis. The 30 kDa human IL33 is converted by CASP1 to a 18 kDa protein. IL33 binds to and signals through ST2 (IL1R1) and its stimulation recruits MYD88, IRAK, IRAK4, and TRAF6, followed by phosphorylation of ERK1(MAPK3)/ERK2(MAPK1), p38(MAPK14), and JNK. The ability of IL-33 to target numerous immune cell types, like Th2-like cells, mast cells, and B1 cells, and to induce cytokine and chemokine production underlines its potential in influencing the outcome of a wide range of diseases, such as arthritis, asthma, atopic allergy & anaphylaxis, cardiovascular disease/atherosclerosis, nervous system diseases, and sepsis.

    Sterility

    0.2 μm filtered

    Immunogen

    Recombinant human IL-33.

    Isotype

    IgG1 kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    0.2μm-filtered solution in PBS, pH 7.4.

    Preservative

    Without preservative

    Handling Advice

    After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.

    Storage

    4 °C,-20 °C

    Storage Comment

    +4°C

    -20°C

    Stable for at least 1 year after receipt when stored at -20°C.

    Expiry Date

    12 months
  • Target

    IL-33 (IL33) (Interleukin 33 (IL33))

    Alternative Name

    IL-33

    Background

    Alternate Names/Synonyms: Interleukin-33, IL-1F11, NF-HEV

    Product Description: Interleukin-33 (IL-33, HF-NEV, IL-1F11), a member of the IL-1 family of cytokines, is expressed by many cell types following pro-inflammatory stimulation and is thought to be released on cell lysis. The 30 kDa human IL33 is converted by CASP1 to a 18 kDa protein. IL33 binds to and signals through ST2 (IL1R1) and its stimulation recruits MYD88, IRAK, IRAK4, and TRAF6, followed by phosphorylation of ERK1(MAPK3)/ERK2(MAPK1), p38(MAPK14), and JNK. The ability of IL-33 to target numerous immune cell types, like Th2-like cells, mast cells, and B1 cells, and to induce cytokine and chemokine production underlines its potential in influencing the outcome of a wide range of diseases, such as arthritis, asthma, atopic allergy & anaphylaxis, cardiovascular disease/atherosclerosis, nervous system diseases, and sepsis.

    UniProt

    O95760

    Pathways

    Production of Molecular Mediator of Immune Response
You are here:
Chat with us!